Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1h-imidazol-4-ylethynyl)pyridine
2. Ro4917523
1. 802906-73-6
2. Ctep Derivative
3. Rg7090
4. 2-chloro-4-((1-(4-fluorophenyl)-2,5-dimethyl-1h-imidazol-4-yl)ethynyl)pyridine
5. Rg-7090
6. Ro4917523
7. Ro-4917523
8. 2-chloro-4-[2-[1-(4-fluorophenyl)-2,5-dimethylimidazol-4-yl]ethynyl]pyridine
9. Noe-101
10. 3110e3ao8s
11. 1034442-21-1 (free Base)
12. 2-chloro-4-(2-(1-(4-fluorophenyl)-2,5-dimethyl-1h-imidazol-4-yl)ethynyl)pyridine
13. Pyridine, 2-chloro-4-(2-(1-(4-fluorophenyl)-2,5-dimethyl-1h-imidazol-4-yl)ethynyl)-
14. 1034442-21-1
15. Basimglurant [usan:inn]
16. Unii-3110e3ao8s
17. 2-chloro-4-[2-[1-(4-fluorophenyl)-2,5-dimethyl-1h-imidazol-4-yl]ethynyl]pyridine
18. Basimglurant [inn]
19. Rg7090basimglurant
20. Rg 7090
21. Ro 4917523
22. Basimglurant (usan/inn)
23. Basimglurant [usan]
24. Basimglurant [who-dd]
25. Schembl560590
26. Gtpl9309
27. Chembl3301626
28. Dtxsid801025734
29. Hms3741c15
30. Bcp15864
31. Zinc6716839
32. Bdbm50071374
33. Mfcd25976719
34. Rg7090rg7090
35. Compound 2 [pmid: 25565255]
36. Cs-3388
37. Db11833
38. Ncgc00390716-02
39. Ac-35776
40. As-51978
41. Hy-15446
42. Ds-015787
43. D10864
44. P14045
45. A916083
46. Q18209947
47. 1-(4-fluorophenyl)-4-[(2-chloro-4-pyridyl)ethynyl]-2,5-dimethyl-1h-imidazole
48. 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1h-imidazol-4-ylethynyl]-pyridine
| Molecular Weight | 325.8 g/mol |
|---|---|
| Molecular Formula | C18H13ClFN3 |
| XLogP3 | 4.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 325.0782033 g/mol |
| Monoisotopic Mass | 325.0782033 g/mol |
| Topological Polar Surface Area | 30.7 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 465 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Basimglurant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Basimglurant, including repackagers and relabelers. The FDA regulates Basimglurant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Basimglurant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Basimglurant supplier is an individual or a company that provides Basimglurant active pharmaceutical ingredient (API) or Basimglurant finished formulations upon request. The Basimglurant suppliers may include Basimglurant API manufacturers, exporters, distributors and traders.
Basimglurant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Basimglurant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Basimglurant GMP manufacturer or Basimglurant GMP API supplier for your needs.
A Basimglurant CoA (Certificate of Analysis) is a formal document that attests to Basimglurant's compliance with Basimglurant specifications and serves as a tool for batch-level quality control.
Basimglurant CoA mostly includes findings from lab analyses of a specific batch. For each Basimglurant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Basimglurant may be tested according to a variety of international standards, such as European Pharmacopoeia (Basimglurant EP), Basimglurant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Basimglurant USP).
LOOKING FOR A SUPPLIER?
